MGT Capital Investments Receives Notice of Extension of Period to Regain Compliance with Failure to Satisfy a Continued Listing
11 Mai 2009 - 2:50PM
PR Newswire (US)
NEW YORK, May 11 /PRNewswire-FirstCall/ -- On May 8, 2009, the
staff of the NYSE Amex (the "Exchange") notified MGT Capital
Investments, Inc. (NYSE Amex: MGT) (the "Company") that it accepted
the Company's plan of compliance and granted the Company an
extension until August 11, 2009 to regain compliance with the
continued listing standards. The Company will be subject to
periodic review by Exchange staff during the extension period.
Failure to make progress consistent with the plan or to regain
compliance with the continued listing standards by the end of the
extension period could result in the Company being delisted from
the NYSE AMEX LLC. On February 10, 2009, the Company received
notice from the Exchange indicating that the Company does not meet
one of the Exchange's continued listing standards due to its
failure to hold an annual meeting of its shareholders in 2008, as
set forth in Section 704 of the Exchange's Company Guide. The
Company was afforded the opportunity to submit a plan of compliance
to the Exchange and, on March 6, 2009, presented its plan to the
Exchange. About MGT Capital Investments, Inc. MGT Capital
Investments, Inc. is a technology holding company that focuses on
investments in the global healthcare information technology market.
The Company has two subsidiaries, Medicsight PLC and Medicexchange
Ltd. Medicsight PLC (AIM: MDST) is a UK-headquartered, research
driven, leading developer of computer-aided detection (CAD) and
image analysis software for the medical imaging market. The CAD
software automatically highlights suspicious areas on computerized
tomography (CT) scans of the colon and lung, helping radiologists
to identify, measure and analyze potential disease and early
indicators of disease. Medicsight's CAD software has been validated
using one of the world's largest and most population diverse
databases of verified patient CT scan data. Medicsight's
ColonCAD(TM) and LungCAD(TM) software products are seamlessly
integrated with the advanced 3D visualization workstations of
several industry-leading imaging equipment partners. Medicexchange
Ltd. provides medical imaging professionals with a global web
portal containing an online sales, jobs and information channel for
diagnostic, treatment and surgery planning solutions. This combined
with a variety of relevant clinical papers, training materials and
content gives these professionals access to information and
products that they otherwise would have difficulty accessing.
Additional information can be found at http://www.mgtci.com/. All
forward-looking statements are made pursuant to the 'safe harbor'
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are based on current management
expectations that involve risks and uncertainties that may result
in such expectations not being realized. Potential risks and
uncertainties include, but are not limited to, the risks described
in company filings with the Securities and Exchange Commission.
Investor & Media enquiries: KCSA Strategic Communications Todd
Fromer / Garth Russell Tel: +1 212-896-1215 / 212-896-1250 /
DATASOURCE: MGT Capital Investments, Inc. CONTACT: Todd Fromer,
+1-212-896-1215, , or Garth Russell, +1-212-896-1250, , both of
KCSA Strategic Communications Web Site: http://www.mgtci.com/
Copyright